Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_431309bc8dab94a0ee0e2aa5aeacd48d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_537aedd607603b452a2b475a3d3afe1f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6056 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-755 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6811 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6815 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-37 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 |
filingDate |
2017-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4849f9dcf5882b464d30c3ca72cc85fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95bc612f8b24fee635ff067094ac1296 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9a43e2a9e20d8feb96e8d052efe2bcb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_891cc700f10e0ab25a2c0b922e14bda4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7f8f35d0040fcbb2e741da278ceae44 |
publicationDate |
2017-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2017149784-A |
titleOfInvention |
Method for reducing immunogenicity against factor VIII in an individual undergoing factor VIII therapy |
abstract |
A method for reducing immunogenicity against factor VIII in an individual receiving factor VIII therapy. The present disclosure provides for a chimeric hybrid comprising FVIII and Fc against a subject at risk of developing an inhibitory FVIII immune response (including anti-FVIII antibodies and / or cell-mediated immunity). Methods of administering a Factor VIII (FVIII) polypeptide are provided. This administration is sufficient to promote clotting and induce immune tolerance to FVIII. The chimeric polypeptide may comprise full length FVIII, or FVIII polypeptide comprising a deletion (eg, complete or partial deletion of the B domain). [Selection] Figure 1 |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11286528-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019077690-A |
priorityDate |
2012-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |